MXCT
MaxCyte, Inc. · Healthcare
Director John Joseph Johnston sold $26K of MaxCyte, Inc.
Sold$25,585
$5.12Price
5,000Shares
−4%Stake
What MXCT did after the filing
- The stock from Tue, Jan 30 close, $5.10
- −18.4%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Mar 13 close.
Traded Fri, Jan 26. Filed Tue, Jan 30, 11:30 AM ET, during the session. Returns use the Jan 30 close and the Mar 13 close. Not investment advice.